Skip to main content

New Products

  • FDA approves new drug for chronic lymphocytic leukemia

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for leukemia made by Genentech, the agency said Friday.

    The FDA announced the approval of Gazyva (obinutuzumab) for treating patients with previously untreated chronic lymphocytic leukemia, in combination with the chemotherapy drug chlorambucil. The drug works by helping certain cells in the immune system attack cancer cells.

  • Brush Buddies introduces new Soniclean Pro Series

    FONTANA, Calif. — Brush Buddies has introduced the new Soniclean Pro available in 5000, 3000 and 2000 models. 

  • Insource Healthcare Solutions to use telehealth systems from Polycom

    SAN JOSE, Calif. – Insource Healthcare Solutions is adding wall-mounted and cart-mounted video systems at the hospitals it operates in upstate New York and Pennsylvania in order to allow for telehealth services and cut costs.

    Polycom said Insource would install its HDX 8000 video systems, which stream video to remote physicians who have corresponding software on their computers and tablets, enabling them to observe, interact with and diagnose patients.

  • Actavis applies for approval of generic version of Absorica

    DUBLIN — Actavis is seeking Food and Drug Administration approval for a generic drug used to treat acne, triggering a lawsuit in a federal court from the maker of the branded version, the company said Thursday.

    The drug maker said it had filed with the FDA for approval of isotretinoin capsules in the 10-mg, 20-mg, 30-mg and 40-mg strengths. The drug is a generic version of Ranbaxy's Absorica, a retinoid used to treat severe, recalcitrant nodular acne in patients 12 and older.

  • Study finds opportunities for mobile health apps to engage patients

    PARSIPPANY, N.J. — The "vast majority" of available mobile apps focused on health and wellness have limited functionality or evidence of value in advancing healthcare provision and outcomes, according to a new report by IMS Health.

  • Impax Labs, Tolmar receive FDA approval for generic version of Solaraze

    HAYWARD, Calif., and FORT COLLINS, Colo.  — Impax Labs and Tolmar announced that the Food and Drug Administration has given final approval to Tolmar's generic version of Solaraze (diclofenac sodium) gel in the 3% strength.

  • HealFast skin care line hits consumer market

    PINE BROOK, N.J.  — After 10 years serving the professional market with products containing ingredients naturally derived from eggs to topically treat severe skin conditions, Fortitude Health has launched its HealFast SkinCare to the consumer marketplace.

  • Nicole by OPI launches Selena Gomez gift sets for holiday

    NEW YORK — Nicole by OPI has launched for the holiday season two new gift sets featuring nail lacquers inspired by actress and singer Selena Gomez.

X
This ad will auto-close in 10 seconds